Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 1CNS 1

Conditions

Breast Neoplasms 214Neoplasms 197Carcinoma, Non-Small-Cell Lung 91Colorectal Neoplasms 89Prostatic Neoplasms 78Lung Neoplasms 75Multiple Myeloma 49Head and Neck Neoplasms 47Melanoma 46Pancreatic Neoplasms 45Neoplasm Metastasis 44Leukemia, Myeloid, Acute 41Carcinoma, Hepatocellular 41Recurrence 37Brain Neoplasms 37Squamous Cell Carcinoma of Head and Neck 34Ovarian Neoplasms 32Glioblastoma 30Precursor Cell Lymphoblastic Leukemia-Lymphoma 29Glioma 29Uterine Cervical Neoplasms 27Sarcoma 27Stomach Neoplasms 26Lymphoma, Non-Hodgkin 26Lymphoma 26Carcinoma, Renal Cell 26Motor Activity 24Lymphoma, Follicular 24Colonic Neoplasms 23Lymphoma, Large B-Cell, Diffuse 22

Interventions

Sodium Chloride 1Saline Solution 1Dexmedetomidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Neuroinflammatory Diseases × 90 days × Clear all
NCT07614243 2026-05-29

ZFAS1-BIPN

The First Affiliated Hospital of Zhejiang Chinese Medical University

Phase NA Completed
22 enrolled
Plasma cell

Neuroinflammatory Diseases, Multiple Myeloma

NCT04266665 2026-03-25

Effect of Dexmedetomidine on Brain Homeostasis and Neurocognitive Outcome

Aristotle University Of Thessaloniki

Phase 4 Completed
56 enrolled
CNS

Neuroinflammatory Diseases, Hypoxia, Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡